ADRs in a Community Hospital – Do These Numbers Look like Yours?;A Gaggle of “Dermatologic” Reactions – TEN,Iodide Mumps,Doxycycline Phototoxicity;Pergolide-Induced Ergotism;Acute Coronary Syndrome Due to Fluorouracil Infusion;Aripiprazole-Induced Acute Dystonic Reaction;Meta-Analysis: Cardiovascular Events and NSAIDs;More on Dopamine Agonists and Impulse Control Disorders
Restricted accessResearch articleFirst published online September, 2006
ADRs in a Community Hospital – Do These Numbers Look like Yours?;A Gaggle of “Dermatologic” Reactions – TEN,Iodide Mumps,Doxycycline Phototoxicity;Pergolide-Induced Ergotism;Acute Coronary Syndrome Due to Fluorouracil Infusion;Aripiprazole-Induced Acute Dystonic Reaction;Meta-Analysis: Cardiovascular Events and NSAIDs;More on Dopamine Agonists and Impulse Control Disorders
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
CuriglianoG., FormicaV., De PasT.. Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy. Ann Oncol.2006; 17: 1174–1175.
2.
WyploszB., ScottéF., Lillo-Le LouëtA., ChevrotA.Recurrent iodide mumps after repeated administration of contrast media. Ann Intern Med.2006; 145: 155–156.
3.
HabifT.P.Doxycycline-induced phototoxicity. N Eng J Med.2006; 355: 182.
DesarkarP., ThakurA., SinhaV.K.Aripiprazole-induced acute dystonia. Am J Psychiatry.2006; 163: 1112–1113.
7.
SalpeterS.R., GregorP., OrmistonT.M.. Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs. Am J Med.2006; 119: 552–559.
8.
ShusterJ.ISMP adverse drug reactions. Hosp Pharm.2005; 40: 946–947.
9.
Weintraubd, SiderowfA.D., PotenzaM.N.. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol.2006; 63: 969–973.
